Jounce Therapeutics
Earnings Date & Report
Last updated:
Jounce Therapeutics’s last earnings date was on 4 May 2023.
Jounce Therapeutics stock Earnings report, Estimates & History
| 2018-08-09 | -0.37 | -0.14 |
|---|---|---|
| 2018-11-13 | -0.34 | -0.23 |
| 2019-03-06 | -0.36 | -0.06 |
| 2019-05-08 | -0.3 | -0.38 |
| 2019-08-07 | -0.28 | -0.21 |
| 2019-11-07 | 2.24 | 2.9 |
| 2020-02-27 | -0.28 | -0.68 |
| 2020-05-06 | -0.57 | -0.78 |
| 2020-08-07 | -0.72 | -0.82 |
| 2020-11-06 | -0.47 | -0.73 |
| 2021-02-25 | 0.22 | 0.86 |
| 2021-05-04 | -0.41 | -0.58 |
| 2021-08-05 | -0.38 | -0.08 |
| 2021-11-04 | -0.4 | -0.59 |
| 2022-03-02 | -0.32 | -0.59 |
| 2022-05-05 | -0.57 | -0.72 |
| 2022-08-04 | -0.68 | -0.65 |
| 2022-11-10 | -0.64 | -0.6 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Jounce Therapeutics stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 4 May 2023 | N/A | -$0.72 | N/A | 22.4M | N/A | |
| 5 Apr 2023 | N/A | $0.95 | N/A | 22.4M | 82M | |
| 10 Nov 2022 | Beat | -$0.64 | -$0.6 | N/A | N/A | Earnings Call Transcript |
| 4 Aug 2022 | Beat | -$0.68 | -$0.65 | N/A | N/A | Earnings Call Transcript |
| 5 May 2022 | Missed | -$0.57 | -$0.72 | N/A | N/A | |
| 2 Mar 2022 | Missed | -$0.32 | -$0.59 | 680K | 27 | |
| 4 Nov 2021 | Missed | -$0.4 | -$0.59 | 6.48M | N/A | Earnings Call Transcript |
| 5 Aug 2021 | Beat | -$0.38 | -$0.08 | 8.18M | 25.36M | Earnings Call Transcript |
| 4 May 2021 | Missed | -$0.41 | -$0.58 | 1.48M | 1.53M | Earnings Call Transcript |
| 25 Feb 2021 | Beat | $0.22 | $0.86 | 107.10M | 62.33M | |
| 6 Nov 2020 | Missed | -$0.47 | -$0.73 | N/A | N/A | |
| 7 Aug 2020 | Missed | -$0.72 | -$0.82 | N/A | N/A | Earnings Call Transcript |
| 6 May 2020 | Missed | -$0.57 | -$0.78 | N/A | N/A | |
| 27 Feb 2020 | Missed | -$0.28 | -$0.68 | 60.88M | N/A | Earnings Call Transcript |
| 7 Nov 2019 | Beat | $2.24 | $2.9 | 92.26M | 119.44M | Earnings Call Transcript |
| 7 Aug 2019 | Beat | -$0.28 | -$0.21 | 23.26M | 17.44M | Earnings Call Transcript |
| 8 May 2019 | Missed | -$0.3 | -$0.38 | 8.66M | 10.98M | |
| 6 Mar 2019 | Beat | -$0.36 | -$0.06 | 120.6M | 20.1M | Earnings Call Transcript |
| 13 Nov 2018 | Beat | -$0.34 | -$0.23 | 21.47M | 14.52M | Earnings Call Transcript |
| 9 Aug 2018 | Beat | -$0.37 | -$0.14 | 51.21M | 19.37M | Earnings Call Transcript |
Jounce Therapeutics Earnings report FAQs
When is Jounce Therapeutics's next Earnings date?
The company has not set the next earnings date yet. The latest Jounce Therapeutics's earnings date was on 5 May 2022.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.